Basic Information
A U.S.-based private company located in Philadelphia, Pennsylvania. In April 2010, Medigene assigned its oncolytic herpes simplex virus (oHSV) development program to Catherex, Inc.
Catherex,Inc.
Pennsylvania,United States of America
101~500 people
--
--
--